• Most Popular
  • Most Shared

Warner Chilcott gets notice from Barr related to generic Femcon

Wed Aug 15, 2007 8:28am EDT

Stocks

   

Aug 15 (Reuters) - Warner Chilcott Ltd. (WCRX.O) said it received a notice from Barr Laboratories Inc. indicating that the latter filed an application with U.S. regulators for a generic version of Warner's oral contraceptive drug.

Regulatory News

Warner said the drug, Femcon FE, is protected by a U.S. patent that expires in 2019, and that it "continues to have full confidence in its intellectual property protecting Femcon FE." (Reporting by Varsha Tickoo in Bangalore)

Regulatory News


More from Reuters

Photo

Accused 9/11 plotters may face NY "Guantanamo"

NEW YORK (Reuters) - If the men accused of plotting the September 11 attacks wonder what conditions they might face when they are moved to New York from Guantanamo Bay for trial, they can expect solitary confinement, 23-hour-a-day lockdowns, constant video surveillance and almost no visitors.

» More Top News
Traders in the oil options pit work at the New York Mercantile Exchange, September 9, 2008. REUTERS/Chip East
Analysis:

"More assumptions, more risk"

New oil and gas reserve rules were supposed to improve transparency, but the unforeseen consequences of the regulations could add a layer of uncertainty for investors.  Full Article 

regulatory news
The sun sets over the Mackenzie Delta near Inuvik, Northwest Territories November 11, 2009. Credit: REUTERS/Jeffrey Jones

An Arctic economy in limbo

Beset by political and economic setbacks, one of the world's biggest pipeline projects is on hold, and it's unclear if the project will ever break ground.  Full Article 

Green Business